FDA reviews initial rapid, take-home exam for HIV

<p>WASHINGTON (AP) — The <span>Food and Drug Administration</span> is deliberation capitulation of a initial over-the-counter HIV exam that would concede consumers to fast exam themselves for a pathogen during home, yet medical supervision.</p>
<p>FDA reviewers pronounced Friday a <span>OraQuick</span> In-Home <span>HIV</span> exam could play a poignant purpose in negligence a widespread of HIV, according to lecture papers posted online. But they also lifted concerns about a correctness of a test, a mouth bandage that earnings formula in about 20 minutes.</p>
<p>The examination comes one day after an FDA advisory row permitted a HIV tablet Truvada for surety use. If FDA follows a group’s advice, a daily remedy would turn a initial drug authorized to forestall healthy people from apropos putrescent with a pathogen that causes AIDS.</p>
<p>Public health experts guess one-fifth, or about 240,000 people, of a 1.2...